Free Pilots Are Killing Your Startup: The Case for Charging in Beta

The cultural battle that determines whether your product has real value or just polite interest

Somewhere in the early stages of every disruptive product launch, a conversation happens — usually internally, sometimes with a prospect — that goes like this. A potential customer wants to try the product. The product is not commercial yet. The team can put a prototype on site, but doing so is expensive, time-consuming, and pulls scarce engineering resources off the build. The prospect's posture is, more or less, “we'll evaluate it for you.” Someone on the team — often a founder, often the engineering lead — argues that the company should provide it for free. We need the validation. We need the case study. We need the relationship. 

This conversation feels like a strategic debate. It is not. It is a referendum on whether your product has real value, and it is being decided on the wrong basis. Get this wrong and you will spend the next eighteen months running expensive free pilots that produce neither revenue nor reliable market data. Get it right and your beta program becomes the foundation of your launch. 

If you cannot charge for it, you have not built a product. You have built a prototype with a charity attached.

There is a particular cultural assumption baked into early-stage technology that says startups should be grateful when an established player agrees to evaluate their product. The framing is that the customer is doing the startup a favor — providing time, attention, infrastructure, feedback — and that the appropriate response is to provide the technology for free in exchange. This framing is so pervasive that it usually goes unchallenged inside the company itself.

Brian Jamison, CEO of Diagnostic Biochips, described this dynamic in detail in a recent LinkedIn Live conversation. As DBC began placing prototypes with early-access customers, the internal pressure to provide them for free was significant. Some of the engineering team genuinely believed it was the right move. Some prospects framed the conversation that way directly — “you should just be grateful, give it to us for free, give us all your labor.” The instinct, especially for a bootstrapped company without a marketing budget for case studies, is to capitulate.

The flip in thinking is straightforward but uncomfortable. As Jamison put it, the “you should be grateful” framing implies that the technology has no value to the customer. If that were true, the customer would not be asking for it. The fact that they are asking — and that they are willing to make their lab, their data, their time available to evaluate it — is itself evidence that the value is real. And if the value is real, payment is appropriate.

The 50-for-50 model

DBC's solution was practical. Rather than charge full retail for an instrument that openly had warts, they offered early-access pricing at roughly half of the eventual commercial list — a 50% discount in exchange for the 50% acknowledgment that the product was beta. Payment terms were flexible. Some customers wrote a check. Some entered into a rental program. Some structured the engagement as a phased payment tied to delivery milestones. The point was not the specific structure. The point was that money changed hands.

This pricing model accomplishes several things at once. It establishes the customer as a buyer rather than an evaluator, which fundamentally changes the dynamics of the relationship. It generates real cash that helps fund the cost of the prototype and the field engineering required to deploy it. It creates a baseline reference price for future customers. And — most importantly — it produces real market data. The Sell Now™ Sales Playbook is explicit about this: the data quality of customer engagement runs from low integrity (internal market research) to critical insights (customer discovery interviews) to real (actually selling). 

Why This Matters For The Data

The strongest argument for charging in beta is not financial. It is epistemic. A free pilot generates polite, agreeable, non-committal feedback from a prospect who has no real stake in the outcome. A paid pilot generates feedback from a customer who has placed a bet on you and now has skin in the game. The conversations are different. The willingness to surface problems is different. The internal champion's level of engagement is different. The probability of conversion to a commercial PO is different by an order of magnitude.

This is also where free pilots produce their most insidious damage. They create the appearance of traction without any of the substance. A pipeline of ten free evaluations looks impressive on a board slide and tells you almost nothing about market readiness. A pipeline of three paid early-access engagements looks smaller and tells you almost everything you need to know. 

The Takeaway

If your team is debating whether to charge for a beta program, the debate itself is the signal. The instinct to give it away is almost always wrong, and the cultural pressure to do so is almost always coming from the wrong place. Charge what you can, structure flexibly, accept value in non-cash forms when appropriate, but do not run free pilots. The prospects who will not engage on those terms are telling you something true. The prospects who will engage on those terms are giving you the only market data that actually matters.

 The first time a customer pays you is the first time you know.